39 related articles for article (PubMed ID: 12210712)
1. Survey on the usage of therapeutic erythrocytapheresis in transfusion services in Italy for the treatment of polycythemia vera, secondary erythrocytosis and hemochromatosis.
Iuliani O; Passeri C; Inghilleri G; Di Bartolomeo E; Abbruzzese L; Bianco I; Foddai ML; Natale GA; De Fusco G; D'Onofrio M; Fadda MG; Dominijanni A; Savignano C; Ostuni A
Transfus Apher Sci; 2023 Oct; 62(5):103752. PubMed ID: 37355441
[TBL] [Abstract][Full Text] [Related]
2. Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.
Shizukuda Y; Smith KP; Tripodi DJ; Arena R; Yau YY; Bolan CD; Waclawiw MA; Leitman SF; Rosing DR
Am J Phys Med Rehabil; 2012 May; 91(5):418-24. PubMed ID: 22311055
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects of therapeutic phlebotomies: Prospective study of 587 procedures.
Romón I; Domíguez-García J; Fernández C; Carretón M; Martínez N; Calzada L; Cortés MA; Mendez GA; Gorostidi I; Briz M; Ocio E
Transfusion; 2024 May; ():. PubMed ID: 38708765
[TBL] [Abstract][Full Text] [Related]
4. Erythrocytapheresis versus phlebotomy in the maintenance treatment of HFE hemochromatosis patients: results from a randomized crossover trial.
Rombout-Sestrienkova E; Winkens B; Essers BA; Nieman FH; Noord PA; Janssen MC; van Deursen CT; Boonen A; Reuser-Kaasenbrood EP; Heeremans J; van Kraaij M; Masclee A; Koek GH
Transfusion; 2016 Jan; 56(1):261-70. PubMed ID: 26358375
[TBL] [Abstract][Full Text] [Related]
5. Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation.
Infanti L; Leitner G; Moe M; Pehlic V; Cattaneo M; Benkert P; Holbro A; Passweg J; Worel N; Buser A
Front Med (Lausanne); 2024; 11():1362941. PubMed ID: 38566922
[TBL] [Abstract][Full Text] [Related]
6. A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.
Rombout-Sestrienkova E; Winkens B; van Kraaij M; van Deursen CTBM; Janssen MCH; Rennings AMJ; Evers D; Kerkhoffs JL; Masclee A; Koek GH
J Clin Apher; 2021 Jun; 36(3):340-347. PubMed ID: 33368569
[TBL] [Abstract][Full Text] [Related]
7. Management of cardiac hemochromatosis.
Aronow WS
Arch Med Sci; 2018 Apr; 14(3):560-568. PubMed ID: 29765443
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis.
Sundic T; Hervig T; Hannisdal S; Assmus J; Ulvik RJ; Olaussen RW; Berentsen S
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s84-9. PubMed ID: 24333062
[TBL] [Abstract][Full Text] [Related]
9. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
10. Management of hemochromatosis. Hemochromatosis Management Working Group.
Barton JC; McDonnell SM; Adams PC; Brissot P; Powell LW; Edwards CQ; Cook JD; Kowdley KV
Ann Intern Med; 1998 Dec; 129(11):932-9. PubMed ID: 9867745
[TBL] [Abstract][Full Text] [Related]
11. In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy.
Muncunill J; Vaquer P; Galmés A; Obrador A; Parera M; Bargay J; Besalduch J
J Clin Apher; 2002; 17(2):88-92. PubMed ID: 12210712
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study.
Rombout-Sestrienkova E; van Noord PA; van Deursen CT; Sybesma BJ; Nillesen-Meertens AE; Koek GH
Transfus Apher Sci; 2007 Jun; 36(3):261-7. PubMed ID: 17569592
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic erythrocytapheresis in the initial treatment of hereditary hemochromatosis.
Rehácek V; Bláha M; Jirousová H; Cernohorská J; Papousek P
Acta Medica (Hradec Kralove); 2012; 55(4):180-5. PubMed ID: 23631289
[TBL] [Abstract][Full Text] [Related]
15. Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis.
Kellner H; Zoller WG
Z Gastroenterol; 1992 Nov; 30(11):779-83. PubMed ID: 1471384
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
